Share on Pinterest A new trial finds that GLP-1 agonists may help reduce knee osteoarthritis-related pain. Westend61/Getty ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

Discover how blood flow restriction (BFR) therapy can enhance knee osteoarthritis recovery by improving pain relief, strength ...

Metabolic syndrome and its individuals components may contribute to the progression of knee OA among both men and women, largely due to high BMI.

Do you suffer from knee pain during or after movement? Does knee pain limit your mobility or prevent you from enjoying some activities you previously found joy in? There is mounting evidence that ...

For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and ...

Discover the potential of semaglutide, the active ingredient in Ozempic and Wegovy, for reducing body weight and knee osteoarthritis-related pain.

Two Labradors have been given a new lease of life thanks to new ground-breaking osteoarthritis treatments that are now available at Harrison Family Vets.